LOKESH R EDARA

Allopathic & Osteopathic Physicians|Allergy & Immunology|Allergy BATTLE CREEK, MI NPI 1104890490

General Payments — all program years on this page

$2,623.93

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 151
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $395.00 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $381.2417
Education $13.761

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $400.9325
2019 $278.8118
2020 $402.3023
2021 $386.3924
2022 $339.5920
2023 $420.9123
2024 $395.0018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086870827 Novartis Pharmaceuticals Corporation $17.23 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086870837 Novartis Pharmaceuticals Corporation $19.09 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086870843 Novartis Pharmaceuticals Corporation $13.22 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086870849 Novartis Pharmaceuticals Corporation $18.97 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086870853 Novartis Pharmaceuticals Corporation $15.26 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114041753 Regeneron Healthcare Solutions, Inc. $15.93 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114041755 Regeneron Healthcare Solutions, Inc. $21.45 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116442147 GlaxoSmithKline, LLC. $22.04 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116662239 GlaxoSmithKline, LLC. $23.58 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137537279 Takeda Pharmaceuticals U.S.A., Inc. $13.76 06/25/2024 Education Undisputed 01/23/2026 View at CMS
1137537282 Takeda Pharmaceuticals U.S.A., Inc. $17.58 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139600594 GENZYME CORPORATION $15.25 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139600612 GENZYME CORPORATION $20.66 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139600634 GENZYME CORPORATION $44.74 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139600646 GENZYME CORPORATION $47.53 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139600650 GENZYME CORPORATION $37.29 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139600694 GENZYME CORPORATION $17.84 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139600712 GENZYME CORPORATION $13.58 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.